Chromatin analysis in human endometrial adenocarcinoma before and after treatment with 6-methyl-17-hydroxyprogesterone acetate (MPA).
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000648:ultrastructure; D000368:Aged; D000782:Aneuploidy; D002467:Cell Nucleus / Q000648:ultrastructure; D002843:Chromatin / Q000032:analysis*; D005260:Female; D006570:Heterochromatin; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D008854:Microscopy, Electron; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000648:ultrastructure
D002843:Chromatin; D006570:Heterochromatin; D008525:Medroxyprogesterone